Sterling Biotech reports standalone net loss of Rs 90.35 crore in the March 2015 quarter

Sales decline 46.53% to Rs 100.63 crore

Net Loss of Sterling Biotech reported to Rs 90.35 crore in the quarter ended March 2015 as against net loss of Rs 103.33 crore during the previous quarter ended March 2014. Sales declined 46.53% to Rs 100.63 crore in the quarter ended March 2015 as against Rs 188.21 crore during the previous quarter ended March 2014. ParticularsQuarter EndedMar. 2015Mar. 2014% Var.Sales100.63188.21 -47 OPM %13.0719.52 -PBDT-63.24-89.07 29 PBT-133.74-152.96 13 NP-90.35-103.33 13

Powered by Capital Market - Live News